Christine Foster – Biography
Last update: April 7, 2026Executive profile
Christine was Chief Business Officer at Memo Therapeutics, and Chief Business Officer at Metagenomi Therapeutics. Christine Foster joined Alloy Therapeutics in 2023.
Christine Foster is currentlyChief Business Officer of Genetic Medicines and Head of Corporate Development at Alloy Therapeutics - View - Alloy Therapeutics org chart
Create your alert
to follow the career of Christine Foster.
Education
Christine Foster has a PhD in Pharmacology from University of Oxford.
They have also studied at University of Oxford :
Find more alumni from University of Oxford
More about Christine Foster
Do you need to know more about Christine Foster? More results.
Participate
Social media
- Christine Foster on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Christine Foster
The colleagues of Christine Foster
Company Colleagues
- At Alloy Therapeutics, Christine Foster has 22 colleagues including Errik Anderson (CEO & Chairman), Fabian Hansen (Director)…
Homonyms
- Christine Foster - Vice President, Product Strategy and Media Operations - 84.51˚
Industry Colleagues
- In the Biotechnology industry, Christine Foster has 35,756 colleagues in 2,407 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Christine Foster.
Get in Touch
Here are a few tips for establishing great contacts.
